Refreshing results…
Targeting CCR7-PI3Kγ overcomes resistance to tyrosine kinase inhibitors in ALK-rearranged lymphoma
UploadPatient‐derived xenograft models of ALK+ ALCL reveal preclinical promise for therapy with brigatinib
UploadResistance to Targeted Agents Used to Treat Paediatric ALK-Positive ALCL
Download from doi.orgThe Role of Autophagy and lncRNAs in the Maintenance of Cancer Stem Cells
Download from doi.orgExistence of reprogrammed lymphoma stem cells in a murine ALCL-like model
Download from www.nature.comNPM-ALK Is a Key Regulator of the Oncoprotein FOXM1 in ALK-Positive Anaplastic Large Cell Lymphoma
Download from doi.orgChallenging perspectives on the cellular origins of lymphoma
Download from royalsocietypublishing.orgMissing publications? Search for publications with a matching author name.